Navigation Links
Hill-Rom to Present at the Canaccord Adams Musculoskeletal Conference
Date:2/11/2009

BATESVILLE, Ind., Feb. 11 /PRNewswire-FirstCall/ -- Hill-Rom Holdings, Inc., (NYSE: HRC) invites you to listen to a presentation by Blair A. Rieth, Jr., vice president, Investor Relations, Communications and Global Brand Development, Hill-Rom. He will be speaking at the Canaccord Adams Musculoskeletal 2009 Conference in Las Vegas on Tuesday, February 24, 2009, at 9:40 a.m. PST.

You are invited to listen to the live audio-only webcast via the internet link at http://ir.hill-rom.com/events.cfm or access it directly at http://www.newswire.ca/en/webcast/viewEvent.cgi?eventID=2550240. A recorded replay of the presentation will be available end of day on February 24 and accessible at the links above until May 26, 2009.

ABOUT HILL-ROM HOLDINGS, INC.

Hill-Rom is a leading worldwide manufacturer and provider of medical technologies and related services for the health care industry, including patient support systems, safe mobility and handling solutions, non-invasive therapeutic products for a variety of acute and chronic medical conditions, medical equipment rentals, and information technology solutions. Hill-Rom's comprehensive product and service offerings are used by health care providers across the health care continuum in hospitals, extended care facilities and home care settings to enhance the safety and quality of patient care.

Hill-Rom ... enhancing outcomes for patients and their caregivers.

www.hill-rom.com


'/>"/>
SOURCE Hill-Rom Holdings, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1

Related medicine news :

1. Hill-Rom Reports First Quarter Revenue Growth of 3.0 Percent to $352 Million and Earnings Per Fully Diluted Share From Continuing Operations of $0.23, an Increase of 15.0 Percent From the Prior Year
2. DRE Medical Equipment Now Sells Reconditioned Hill-Rom Hospital Beds
3. Hill-Rom Holdings, Inc. Invites You to Join Its Fiscal 2009 First Quarter Earnings Webcast
4. Hill-Rom Reports First Quarter Revenue of $350 Million and Announces Further Actions to Address Challenging Economic Environment
5. JCR, Hill-Rom Launch Nurse Safety Scholar-in-Residence Program
6. Hill-Rom Announces First Quarter 2009 Dividend
7. Hill-Rom Wins Gold Brandon Hall Learning Award
8. Hill-Rom Holdings, Inc. Invites You to Join Its Fiscal 2008 Fourth Quarter and Year End Earnings Webcast
9. Hill-Rom Announces Agreement with Encompass Therapeutic Support Systems Adding New Surface Choice for Use with Hill-Rom Frames
10. Hill-Rom Reports Third Quarter Revenue Growth of 11.7 Percent to $366.8 Million and Earnings Per Fully Diluted Share From Continuing Operations of $0.34, an Increase of 89 Percent From the Prior Year
11. Hill-Rom Holdings, Inc. Invites You to Join its Fiscal 2008 Third Quarter Earnings Webcast
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Medicine Technology:Onyx Pharmaceuticals to Webcast Analyst Briefing on Development Program 2Dynatronics Receives 180-Day NASDAQ Extension 2ARKRAY, Inc. Receives FDA 510k Clearance on the Assure(R) Platinum Auto-Code Blood Glucose Monitoring System 2Kevin Niksarli M D Of Newsight Laser Center New York N Y Reminds Early Detection Critical to Slowing Progress of Glaucoma on 6 17 2009 49538 1Kevin Niksarli M D Of Newsight Laser Center New York N Y Reminds Early Detection Critical to Slowing Progress of Glaucoma on 6 17 2009 49538 2RSA Designated as the Leader in One Time Password Market by Frost 26 Sullivan 8936 1RSA Designated as the Leader in One Time Password Market by Frost 26 Sullivan 8936 2RSA Designated as the Leader in One Time Password Market by Frost 26 Sullivan 8936 3RSA Designated as the Leader in One Time Password Market by Frost 26 Sullivan 8936 4Cell Therapeutics Announces Final Results of its Fixed Price Exchange Offers for Any and All of its 24118 9 Million Convertible Notes Outstanding 49533 1Cell Therapeutics Announces Final Results of its Fixed Price Exchange Offers for Any and All of its 24118 9 Million Convertible Notes Outstanding 49533 2Cell Therapeutics Announces Final Results of its Fixed Price Exchange Offers for Any and All of its 24118 9 Million Convertible Notes Outstanding 49533 3